Pulmonary antifibrotic mechanisms aspirin-triggered lipoxin A(4) synthetic analog.
作者： Rafael F. Guilherme , Debora G. Xisto , Steven L. Kunkel , Célio G. Freire-de-Lima , Patricia R.M. Rocco
关键词:
摘要: … We investigated the mechanisms involved in its effect and found that systemic treatment with ATLa 1 week after BLM instillation considerably reversed the inflammatory response, total …
sci-hub.se 参考文章(46)
Paola Maderna, Catherine Godson, Lipoxins: resolutionary road British Journal of Pharmacology. ,vol. 158, pp. 947- 959 ,(2009) , 10.1111/J.1476-5381.2009.00386.X
Vanessa Martins, Samuel S. Valença, Francisco A. Farias-Filho, Raphael Molinaro, Rafael L. Simões, Tatiana P. T. Ferreira, Patrícia M. R. e Silva, Cory M. Hogaboam, Steven L. Kunkel, Iolanda M. Fierro, Claudio Canetti, Claudia F. Benjamim, ATLa, an Aspirin-Triggered Lipoxin A4 Synthetic Analog, Prevents the Inflammatory and Fibrotic Effects of Bleomycin-Induced Pulmonary Fibrosis Journal of Immunology. ,vol. 182, pp. 5374- 5381 ,(2009) , 10.4049/JIMMUNOL.0802259
Clary B. Clish, Bruce D. Levy, Nan Chiang, Hsin-Hsiung Tai, Charles N. Serhan, Oxidoreductases in Lipoxin A4 Metabolic Inactivation A NOVEL ROLE FOR 15-OXOPROSTAGLANDIN 13-REDUCTASE/LEUKOTRIENE B4 12-HYDROXYDEHYDROGENASE IN INFLAMMATION Journal of Biological Chemistry. ,vol. 275, pp. 25372- 25380 ,(2000) , 10.1074/JBC.M002863200
Isabelle Vachier, Caroline Bonnans, Claude Chavis, Martine Farce, Philippe Godard, Jean Bousquet, Pascal Chanez, Severe asthma is associated with a loss of LX4, an endogenous anti-inflammatory compound Journal of Allergy and Clinical Immunology. ,vol. 115, pp. 55- 60 ,(2005) , 10.1016/J.JACI.2004.09.038
Bruna PF Fonseca, Priscilla C Olsen, Luciana P Coelho, Tatiana PT Ferreira, Heitor S Souza, Marco A Martins, Joao PB Viola, NFAT1 Transcription Factor Regulates Pulmonary Allergic Inflammation and Airway Responsiveness American Journal of Respiratory Cell and Molecular Biology. ,vol. 40, pp. 66- 75 ,(2009) , 10.1165/RCMB.2007-0102OC
Glenda Trujillo, Erica C. O'Connor, Steven L. Kunkel, Cory M. Hogaboam, A Novel Mechanism for CCR4 in the Regulation of Macrophage Activation in Bleomycin-Induced Pulmonary Fibrosis The American Journal of Pathology. ,vol. 172, pp. 1209- 1221 ,(2008) , 10.2353/AJPATH.2008.070832
TA Wynn, Cellular and molecular mechanisms of fibrosis. The Journal of Pathology. ,vol. 214, pp. 199- 210 ,(2008) , 10.1002/PATH.2277
Luc M Delaunois, Mechanisms in pulmonary toxicology. Clinics in Chest Medicine. ,vol. 25, pp. 1- 14 ,(2004) , 10.1016/S0272-5231(03)00122-9
Otylia Kowal-Bielecka, Krzysztof Kowal, Oliver Distler, Joanna Rojewska, Anna Bodzenta-Lukaszyk, Beat A. Michel, Renate E. Gay, Steffen Gay, Stanislaw Sierakowski, Cyclooxygenase- and lipoxygenase-derived eicosanoids in bronchoalveolar lavage fluid from patients with scleroderma lung disease: An imbalance between proinflammatory and antiinflammatory lipid mediators Arthritis & Rheumatism. ,vol. 52, pp. 3783- 3791 ,(2005) , 10.1002/ART.21432
Bruce D. Levy, George T. De Sanctis, Pallavi R. Devchand, Eugene Kim, Kate Ackerman, Birgitta A. Schmidt, Wojciech Szczeklik, Jeffrey M. Drazen, Charles N. Serhan, Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4). Nature Medicine. ,vol. 8, pp. 1018- 1023 ,(2002) , 10.1038/NM748